A Phase I Study of Anti-CD3 x Anti-Her2/neu (HER2Bi) Armed Activated T Cells (ATC) in Patients with Breast Cancer Leptomeningeal Metastases

IRB/UVA Tracking #
20805
Contact
Heather L Lothamer
Contact Email
Contact Phone
1.434.924.9924
Phase
I
Primary purpose
Treatment
Cancer PI
Camilo Fadul
Status
OPEN TO ACCRUAL
Ages
Adult